Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ashkan Pirmani"'
Publikováno v:
JMIR Formative Research, Vol 8, p e55496 (2024)
BackgroundThe integrity and reliability of clinical research outcomes rely heavily on access to vast amounts of data. However, the fragmented distribution of these data across multiple institutions, along with ethical and regulatory barriers, present
Externí odkaz:
https://doaj.org/article/7aa9956a1c6e443dbe74cf12d2bef5e6
Publikováno v:
JMIR Medical Informatics, Vol 11, p e48030 (2023)
BackgroundInvestigating low-prevalence diseases such as multiple sclerosis is challenging because of the rather small number of individuals affected by this disease and the scattering of real-world data across numerous data sources. These obstacles i
Externí odkaz:
https://doaj.org/article/9fa2536138e84651a25c49c905bfebf4
Autor:
Lotte Geys, Tina Parciak, Ashkan Pirmani, Robert McBurney, Hollie Schmidt, Tanja Malbaša, Tjalf Ziemssen, Arnfin Bergmann, Juan I. Rojas, Edgardo Cristiano, Juan Antonio García-Merino, Óscar Fernández, Jens Kuhle, Claudio Gobbi, Amber Delmas, Steve Simpson-Yap, Nupur Nag, Bassem Yamout, Nina Steinemann, Pierrette Seeldrayers, Bénédicte Dubois, Ingrid van der Mei, Alexander Stahmann, Jelena Drulovic, Tatjana Pekmezovic, Waldemar Brola, Mar Tintore, Nynke Kalkers, Rumen Ivanov, Magd Zakaria, Maged Abdel Naseer, Wim Van Hecke, Nikolaos Grigoriadis, Marina Boziki, Adriana Carra, Mikolaj A. Pawlak, Ruth Dobson, Kerstin Hellwig, Arlene Gallagher, Letizia Leocani, Gloria Dalla Costa, Nise Alessandra de Carvalho Sousa, Bart Van Wijmeersch, Liesbet M. Peeters
Publikováno v:
International Journal of MS Care. 23:261-268
Background: One of the major objectives of the Multiple Sclerosis Data Alliance (MSDA) is to enable better discovery of multiple sclerosis (MS) real-world data (RWD). Methods: We implemented the MSDA Catalogue, which is available worldwide. The curre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c89c7df4cd7ae9f6a1e0d7dde9efbe0b
https://doi.org/10.7224/1537-2073.2021-006
https://doi.org/10.7224/1537-2073.2021-006
Autor:
Georgina Arrambide, Ingrid van der Mei, Raed Alroughani, Lars Forsberg, Rodden M. Middleton, Guilherme Sciascia do Olival, Nikola Lazovski, Rumen Ivanov, Alexander Stahmann, Tomas Kalincik, Helmut Butzkueven, Richard S. Nicholas, J. Hillert, Alice Estavo Dias, Edward De Brouwer, Amber Salter, Serkan Ozakbas, Nupur Nag, Doralina Guimarães Brum, Alexander Fidao, Anna Zabalza, Yves Moreau, Ricardo Alonso, Anneke Van Der Walt, Nick Rijke, Lotte Geys, Anibal Chertcoff, Arnfin Bergmann, Robert N. McBurney, Clare Walton, Anna Glaser, Tina Parciak, Gilles Edan, Clément Gautrais, Ashkan Pirmani, Maria Fernanda Mendes, Juan Ignacio Rojas, Melinda Magyari, Liesbet M. Peeters, Robert J. Fox, Hollie Schmidt, Amin Ardeshirdavanai, Steve Simpson-Yap, Stefan Braune, Giancarlo Comi, Johana Bauer, Tim Spelman
Publikováno v:
Scientia
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Neurology
article-version (Version of Record) 3
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Neurology
article-version (Version of Record) 3
Made available in DSpace on 2022-04-28T19:46:29Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-11-09 Background and ObjectivesPeople with multiple sclerosis MS are a vulnerable group for severe coronavirus disease 2019 COVID-19, particularly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdbb50404f289c1a781c29206cd86560
https://doi.org/10.1212/wnl.0000000000012753
https://doi.org/10.1212/wnl.0000000000012753
Autor:
Ploingarm, Petsophonsakul, Ashkan, Pirmani, Edward, De Brouwer, Murat, Akand, Wouter, Botermans, Frank, Van Der Aa, Joris Robert, Vermeesch, Fritz, Offner, Roel, Wuyts, Yves, Moreau, Ingrid, Maes, Ines, Blockx, Patricia, Van Rompuy, Martine, Lewi, Bart, Vannieuwenhuyse
Publikováno v:
Studies in health technology and informatics. 294
The complexity and heterogeneity of cancers leads to variable responses of patients to treatments and interventions. Developing models that accurately predict patient's care pathways using prognostic and predictive biomarkers is increasingly importan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::257191061b58c8f5b71c3950dddfd189
https://pubmed.ncbi.nlm.nih.gov/35612220
https://pubmed.ncbi.nlm.nih.gov/35612220
Autor:
Ploingarm Petsophonsakul, Ashkan Pirmani, Edward De Brouwer, Murat Akand, Wouter Botermans, Frank Van Der Aa, Joris Robert Vermeesch, Fritz Offner, Roel Wuyts, Yves Moreau, Ingrid Maes, Ines Blockx, Patricia Van Rompuy, Martine Lewi, Bart Vannieuwenhuyse
The complexity and heterogeneity of cancers leads to variable responses of patients to treatments and interventions. Developing models that accurately predict patient’s care pathways using prognostic and predictive biomarkers is increasingly import
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2a1a4f753e513d899ee6b81406839b5
https://doi.org/10.3233/shti220601
https://doi.org/10.3233/shti220601
Autor:
Steve Simpson-Yap, Ashkan Pirmani, Edward De Brouwer, Liesbet M. Peeters, Lotte Geys, Tina Parciak, Anne Helme, Jan Hillert, Yves Moreau, Gilles Edan, Tim Spelman, Sifat Sharmin, Robert McBurney, Hollie Schmidt, Arnfin Bergmann, Stefan Braune, Alexander Stahmann, Rodden Middleton, Amber Salter, Bruce Bebo, Anneke van der Walt, Helmut Butzkueven, Serkan Ozakbas, Rana Karabudak, Cavit Boz, Raed Alroughani, Juan I Rojas, Ingrid van der Mei, Guilherme Sciascia do Olival, Melinda Magyari, Ricardo Alonso, Richard Nicholas, Anibal Chertcoff, Ana Zabalza, Georgina Arrambide, Nupur Nag, Annabel Descamps, Lars Costers, Ruth Dobson, Aleisha Miller, Paulo Rodrigues, Vesna Prčkovska, Giancarlo Comi, Tomas Kalincik
Publikováno v:
Multiple sclerosis and related disorders. 66
Interferon-β, a disease-modifying therapy (DMT) for MS, may be associated with less severe COVID-19 in people with MS.Among 5,568 patients (83.4% confirmed COVID-19), interferon-treated patients had lower risk of severe COVID-19 compared to untreate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1461b04ac09c098655cd4e480f1a2b58
https://pubmed.ncbi.nlm.nih.gov/35917745
https://pubmed.ncbi.nlm.nih.gov/35917745
Autor:
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, Edward De Brouwer, Lotte Geys, Tina Parciak, Anne Helme, Nick Rijke, Jan A. Hillert, Yves Moreau, Gilles Edan, Sifat Sharmin, Tim Spelman, Robert McBurney, Hollie Schmidt, Arnfin B. Bergmann, Stefan Braune, Alexander Stahmann, Rod M. Middleton, Amber Salter, Bruce Bebo, Anneke Van der Walt, Helmut Butzkueven, Serkan Ozakbas, Cavit Boz, Rana Karabudak, Raed Alroughani, Juan I. Rojas, Ingrid A. van der Mei, Guilherme Sciascia do Olival, Melinda Magyari, Ricardo N. Alonso, Richard S. Nicholas, Anibal S. Chertcoff, Ana Zabalza de Torres, Georgina Arrambide, Nupur Nag, Annabel Descamps, Lars Costers, Ruth Dobson, Aleisha Miller, Paulo Rodrigues, Vesna Prčkovska, Giancarlo Comi, Liesbet M. Peeters
Publikováno v:
Simpson-Yap, S, Pirmani, A, Kalincik, T, De Brouwer, E, Geys, L, Parciak, T, Helme, A, Rijke, N, Hillert, J A, Moreau, Y, Edan, G, Sharmin, S, Spelman, T, McBurney, R, Schmidt, H, Bergmann, A B, Braune, S, Stahmann, A, Middleton, R M, Salter, A, Bebo, B, Van der Walt, A, Butzkueven, H, Ozakbas, S, Boz, C, Karabudak, R, Alroughani, R, Rojas, J I, van der Mei, I A, Sciascia do Olival, G, Magyari, M, Alonso, R N, Nicholas, R S, Chertcoff, A S, de Torres, A Z, Arrambide, G, Nag, N, Descamps, A, Costers, L, Dobson, R, Miller, A, Rodrigues, P, Prčkovska, V, Comi, G & Peeters, L M 2022, ' Updated Results of the COVID-19 in MS Global Data Sharing Initiative : Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity ', Neurology(R) neuroimmunology & neuroinflammation, vol. 9, no. 6 . https://doi.org/10.1212/NXI.0000000000200021
Scientia
Scientia
Background and Objectives Certain demographic and clinical characteristics, including the use of some disease-modifying therapies (DMTs), are associated with severe acute respiratory syndrome coronavirus 2 infection severity in people with multiple s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3b929933976d6b2caf0a28fda3618f6
https://pubmed.ncbi.nlm.nih.gov/36038263
https://pubmed.ncbi.nlm.nih.gov/36038263
Autor:
Lotte Geyes, Nikola Lazovski, Ingrid van der Mei, Ricardo Alonso, Anna Glaser, Tomas Kalincik, Tina Parciak, Rumen Ivanov, Richard Nicholas, Arnfin Bergmann, Gilles Edan, Ashkan Pirmani, Hollie Schmidt, Amber Salter, Robert J. Fox, Steve Simpson-Yap, Johana Bauer, Jan Hillert, Liesbet Peeters, Giancarlo Comi, Amin Ardeshirdavani, Helmut Butzkueven, Alexander Fidao, Anibal Chertcoff, Alice Estavo Dias, Robert N. McBurney, Melinda Magyari, Lars Forsberg, Ana Zabalza, Georgina Arrambide, Alexander Stahmann, Rodden M. Middleton, Nupur Nag, Doralina Guimarães Brum, Nick Rijke, Guilherme Sciascia do Olival, Tim Spelman, Juan Ignacio Rojas, Edward De Brouwer, Clare Walton, Anneke van der Walt, Clément Gautrais, Maria Fernandes Mendes, Stefan Braune
Publikováno v:
International Journal of Epidemiology. 50
Background People with multiple sclerosis (MS) are a vulnerable group for severe COVID-19, particularly those taking immunosuppressive disease-modifying therapies (DMTs). We examined the characteristics of COVID-19 severity in an international sample
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec6c0ecd24b8515b27b91736b9e19442
https://doi.org/10.1093/ije/dyab168.604
https://doi.org/10.1093/ije/dyab168.604
Autor:
Tomas Kalincik, Nick Rijke, Ingrid van der Mei, Clare Walton, Clément Gautrais, Stefan Braune, Yves Moreau, Tim Spelman, Robert McBurney, Georgina Arrambide, Guilherme Sciascia do Olival, Juan Ignacio Rojas, Edward De Brouwer, Jan Hillert, Amin Ardeshirdavani, Ashkan Pirmani, Giancarlo Comi, Lotte Geys, Anna Glaser, Alice Estavo Dias, Alexander Stahmann, Doralina Guimarães Brum, Alexander Fidao, Melinda Magyari, Rumen Ivanov, Lars Forsberg, Amber Salter, Rodden M. Middleton, Nikola Lazovski, Anneke van der Walt, R. Alroughani, Serkan Ozakbas, Liesbet M. Peeters, Helmut Butzkueven, Maria Fernanda Mendes, Anibal Chertcoff, Arnfin Bergmann, Hollie Schmidt, Nupur Nag, Tina Parciak, Richard Nicholas, Gilles Edan, Steve Simpson-Yap, Robert J. Fox, Johana Bauer, Ricardo Alonso, Anna Zabalza
BackgroundPeople with multiple sclerosis (MS) are a vulnerable group for severe COVID-19, particularly those taking immunosuppressive disease-modifying therapies (DMTs). We examined the characteristics of COVID-19 severity in an international sample
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::083d5ffb4f7b35ab0c096b132d4c7804
https://doi.org/10.1101/2021.02.08.21251316
https://doi.org/10.1101/2021.02.08.21251316